Baricitinib in New-onset Type 1 Diabetes

NCT04774224 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

OTHER

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: Baricitinib
DRUG: Placebo

Sponsor

St Vincent's Institute of Medical Research

Collaborators

[object Object]
[object Object]